Peer-influenced content. Sources you trust. No registration required. This is HCN.

Oncology News Central (ONC)AUA/SUO Release an Amendment to the Advanced Prostate Cancer Guideline

On April 25, 2023, the American Urological Association (AUA), in partnership with the Society of Urologic Oncology (SUO), released the 2023 clinical practice guideline amendment for the management of advanced prostate cancer. This guideline contains a total of 40 recommendations, and the revision includes updates to recommendations under these disease states:

  • Biochemical recurrence (“rising PSA state”) without metastatic disease when all local therapy options have been exhausted
  • Metastatic hormone-sensitive prostate cancer
  • Non-metastatic castration-resistant prostate cancer
  • Metastatic castration-resistant prostate cancer
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form